Connect with us

Businessuite Markets

Indies Pharma Jamaica Crosses The J$1B Line In Earned Gross Revenues For Fiscal 2023

Published

on

Vishnu V. Muppuri (Mrs.) Co-Founder, Executive Director & COO for Indies Pharma Jamaica Limited Has Released The Following Twelve-Months Unaudited Financial Results For The Period Ending 31 October, 2023.

For the Twelve months ended October 31, 2023, Indies Pharma Jamaica Limited earned gross revenues of J$1,055 billion, 12.61% higher than the J$937 million in the prior comparable period of 2022.

Gross profit for the Twelve months increased to J$727 million, representing a 10.83% increase or J$71 million when compared to a similar period in 2022. This is attributable mainly to the enhanced customer loyalty towards the company’s product and service quality. The main contributor to our gross margin is increase in the sales which has provided us a favorable impact on our contribution and profitability.

Administrative expenses increased by 23.06% or J$86 million year over year principally due to a higher level of fleet vehicle maintenance, salaries, and royalty obligation.

The ‘Profit from Operations increased by 0.24% of J$283.5 million in 2023 when compared with $282.8 million during the same period of 2022. This increase in admin expenses also caused ‘Net Profit for the twelve months’ to decrease by 4.71% to J$210 million from J$220 million for the same twelve-month period of 2022.

In addition to the above, as of the last quarter of this fiscal year, the five-year zero corporate income tax (CIT) incentive period has come to an end. Going forward the company’s performance will now attract a CIT bracket of 12.5% over the next 5 years. Despite 12.5% CIT being applied during the last quarter of the current fiscal year, the company delivered the net profits almost the same as last year which resonates with the ethos of the company, stability, and consistency in delivering the positive yield to the investors.

Total assets at the end of the Twelve months stood at J$2.2 billion which represents an 8% increase or $158 million to the comparative period of 2022, the major contributor being the value increment in the intangible assets (Favorable) from J$379 million in 2022 to J$440 million in 2023 (J$61Million Movement).

Shareholders’ equity has increased by 5.14% this year to J$1.216 billion compared to J$1.156 billion in the prior period of 2022 and total liabilities increased by 11.13% in 2023 to J$990 million from J$891 million in 2022. The main contributing factor to the increase in total liability is the extension granted to occupied leased premises.

❖ Earnings per share (EPS) is S0.1578 for the twelve-months period in 2023 compared to $0.1656 for the same period in 2022.

Results For The Fourth Quarter Ended 31 October 2023

For the fourth quarter that ended October 2023, revenues increased by J$59 million (28.10%) to end at J$268 million from J$209 million in the corresponding periods of 2022. This is a result of the strong demand for the Indies Pharma products along with the strategies implemented to drive sales.

Gross profit for the quarter increased to $172 million which represented an increase of 25.05% or $34 million in comparison to $137 million for the previous quarter 2022. The main contribution came from our sales volume and value increment.
Other contributing factors are the robust approach taken in monitoring inventory and mitigating the writing-off of expired stock.

Administrative Expenses increased by 24.24% (J$22 million) to $116 million for the current quarter in comparison to $93.5 million in the corresponding quarter of the prior year.

Increased expenditures in several areas including Bioprist Royalty expenses, because of a change in accounting policy re the computation, accrual process, and booking of same. This increase was expected in this current year of adoption; however, this will normalize in the subsequent year.

Building maintenance & repairs, Admin & Drug permits and motor vehicle expenses were also contributory factors to the operating expenses (Opex) increase.

Net Profit for the three months has increased by 4.48% to J$34 million from J$33 million during the same three-month period in 2023 and 2022 respectively.

The $805 million bond attained in 2020 towards “Growth Capital” continues to remain on the books as we continue to grow the company through the organic development and approval of two new drugs at the USFDA for the United States Market.

As stated in our 2nd Quarter JSE filing, we have successfully submitted our very first ANDA – Abbreviated New Drug Application (generic drug dossier) on the 25 January 2023 at the USFDA. The same was accepted by the USFDA without any rejections or queries on the 24th of February 2023 with a gold date of approval as November 2023. Queries from the USFDA during this fourth quarter were uneventful and were effectively addressed and filed by us.

❖ Earnings per share (EPS) is $0.0258 during the fourth quarter of 2023 compared to $0.0248 for the same period in 2022.

The Company remains healthy, growth focused and continues to deliver and maintain a consistent upward trend in its performance and profitability to its shareholders.

For More Information CLICK THIS LINK

Businessuite Markets

Prestige Holdings Enjoyed A Strong Performance For First Quarter Of Fiscal 2024.

Published

on

Christian E. Mouttet Chairman for Prestige Holdings has released the following Consolidated Unaudited Results for the Three Months Ended 29 February 2024

I am pleased to report that Prestige Holdings enjoyed a strong performance for the First Quarter of fiscal 2024. Group sales increased by 10% to $341 million from $309 million in the prior year, which resulted in a Profit Before Tax of $15.3 million compared to a profit of $11.6 million for the same period in 2023, a 32% increase. Profit After Tax, attributable to shareholders, increased by 25% from $7.8 million to $9.8 million. Cash flow from operations was $26.9 million and we ended the quarter with $100 million in cash having reduced total borrowings by $5.8 million. During the period we remodelled 2 restaurants and ended the period with 134 restaurants.

All brands posted solid performances during the quarter, with our Subway and Pizza Hut results driven by improved operations, efficiencies and strong demand for our innovative menu items and value offerings. Top line sales were impacted by the opening of five new Starbucks restaurants at Brentwood, Aranguez, O’Meara, St. Augustine and Amazonia Mall, Guyana, when compared to the First Quarter of 2023.

I am extremely pleased to report that KFC recently achieved a significant milestone of serving 150,000 Harvest Meals. The Harvest Meal Programme, which has been active for two years, is designed to provide unsold KFC food to participating NGOs in Trinidad and Tobago. This unsold food is carefully packaged and transported, following accepted global food safety protocols, and is then repurposed into delicious meals and served to the less fortunate. We are very happy to have the opportunity to positively impact the communities in which we operate by partnering with NGOs to provide meals to those in need.

As mentioned in my previous report, significant investment is planned in this financial year for new store development, including Guyana, as well as the remodelling of existing assets in Trinidad and Tobago. We expect these developments, as well as our continued brand initiatives, to continue to deliver positive results.
For More Click THIS LINK

Continue Reading

Businessuite Markets

GraceKennedy’s Strategic Spur Tree Spices Acquisition: Positioning For Growth

Published

on

GraceKennedy Limited’s recent acquisition of an increased stake in Spur Tree Spices (Jamaica) Limited has positioned it as the second-largest shareholder in the company. With an estimated 338,410,375 shares now under its belt, based on Spur Tree’s issued share count of 1,676,959,244 ordinary shares, GraceKennedy solidifies its influence in Jamaica’s culinary landscape.

Continued Expansion through M&A

This transaction marks the latest in GraceKennedy’s series of mergers and acquisitions (M&A) activities, reflecting the company’s aggressive growth strategy. Following its acquisitions of Scotia Insurance Caribbean Limited and Unibev Limited in 2023, as well as doubling its interest in Catherine’s Peak Bottling Company Limited to 70% in February 2023, GraceKennedy demonstrates its commitment to diversification and market expansion.

Spur Tree’s Strategic Evolution

Meanwhile, Spur Tree Spices is undergoing a strategic transformation, expanding beyond spices and seasonings to become a full-fledged food brand. With plans to launch more than two dozen new products on May 1 and a brand refresh to reflect its new focus, Spur Tree is poised for a significant market repositioning.

Diversification and Innovation

In the upcoming quarter, Spur Tree Spices is set to unveil an array of innovative products, including their much-anticipated line of dried spices. This strategic move represents the company’s foray into new categories and a substantial expansion of its product offerings. By diversifying its portfolio, Spur Tree aims to capture a broader consumer base and solidify its position as a leading player in the culinary industry.

Implications of the Acquisition

GraceKennedy’s increased stake in Spur Tree Spices not only strengthens its position in the spice market but also opens doors for collaboration and synergies between the two entities. As GraceKennedy continues to expand its presence through strategic acquisitions, it can leverage Spur Tree’s innovative product line-up to bolster its offerings and tap into new market segments.

GraceKennedy Limited’s acquisition of a significant stake in Spur Tree Spices marks a strategic milestone for both companies. With GraceKennedy’s growing influence and Spur Tree’s strategic evolution, the stage is set for a dynamic partnership that promises innovation, growth, and market leadership. As they navigate the evolving landscape of Jamaica’s culinary industry, GraceKennedy and Spur Tree Spices are poised to redefine the future of food, one spice at a time.

Continue Reading

Businessuite Markets

ANSA McAL Group Announces Formation Of Joint Venture Company, Globus ANSA Private Limited, With Globus Spirits Limited In India.

Published

on

A. Norman Sabga Executive Chairman of the ANSA McAL Group of Companies has announced the formation of the joint venture company, Globus ANSA Private Limited, with Globus Spirits Limited in India.

In a release posted on the Trinidad and Tobago Stock Exchange ANSA McAL confirmed that with effect from 4th April 2024, ANSA McAL Limited (“ANSA McAL”) entered into a joint venture agreement with Globus Spirits Limited (“GSL”) to establish Globus ANSA Private Limited (“GAPL”).

Each party will hold fifty percent (50%) of the issued and allotted ordinary share capital of GAPL.

“This collaboration signifies a new era in the Indian alcoholic beverages industry, driving innovation and growth, ‘

“Globus ANSA Private Limited will specialise in manufacturing and distributing alcoholic beverages across the Indian subcontinent, leveraging the strength of both ANSA McAL and Globus Spirits Limited,” said Mr. Shekhar Swarup, Managing Director for Globus Spirits Limited. “This collaboration signifies a new era in the Indian alcoholic beverages industry, driving innovation and growth, ‘he stated

 

 

 

Globus Spirits Ltd is one of the leading players in the Alcohol industry in North India distributing brands in the Consumer Segment including:
• GR8 Times.
• Rajputana.
• Globus Spirits Dry Gin.
• White. Lace.
• Governors’ Reserve Red.
• Governors’ Reserve Blue.
• Oakton.
• Laffaire. Napoleon.

Trinidad and Tobago conglomerate ANSA McAL Group has over 142 years of rich history representing many world-renowned brands, including some of their own home-grown successes. The partnership marks a significant milestone in ANSA McAL Group’s journey, merging cultures and expertise to revolutionise the beer industry in India, with their icon Carib brand and leading the charge.

Norman Sabga Executive Chairman of the ANSA McAL Group of Companies, highlighted the immense opportunities in India and their commitment to delivering unparalleled value through this partnership.

“We are confident that our collaboration will allow us to seize the growing demand for high quality beverages by captivating palates with our distinctive products” he said

ANSA McAL is now poised to be an equal Shareholder of GAPL, an Indian company which
would produce, market, sell, distribute and retail beer and other beverages.

Continue Reading

Businessuite Markets

Jamaica Broilers Group Reporting Strong Top and Bottom Line Performance for January 2024 Quarter

Published

on

Christopher E. Levy Group President & CEO of Jamaica Broilers Group Limited now release the following unaudited financial results for the quarter ended January 27, 2024, which have been prepared in accordance with International Financial Reporting Standards (IFRS).

The Group produced a net profit attributable to shareholders of $1.3 billion, for the quarter ended January 27, 2024. The operations of the Group continue to be strong, and our gross margins are consistent with expectations.

Quarterly Group revenues amounted to $23.6 billion, a 4% increase above the $22.7 billion achieved in the corresponding quarter.

Our gross profit for the quarter was $5.9 billion, a 7% increase above the $5.5 billion achieved in the corresponding quarter in the prior year.

Jamaica Operations reported a segment result of $5.9 billion which was $448 million or 8% above last year’s segment result. Total revenue for our Jamaica Operations showed an increase of 2% over the prior year nine-month period. This increase was primarily driven by the growth in the sale and export of poultry and implementation of cost containment efforts.

Our US Operations reported a segment result of $3 billion which was $226 million or 8% above last year’s segment result. This increase was driven by increased volumes of poultry meat and eggs, as well as the implementation of cost management initiatives.
Total revenue for the US Operations increased by 3% over the prior year nine-month period.

We have begun to realise additional volumes through the US operations, which has resulted in increased financing requirements primarily around working capital.

For More Information CLICK HERE

Continue Reading

Businessuite Markets

Main Event Reporting Net Profit Of JA$100M For Quarter Ended January 2024

Published

on

Solomon Sharpe Chief Executive Officer of Main Event Entertainment Group Limited has released the following unaudited financial statements for the quarter ended January 31, 2024 (Q1).

The company continues to have solid results in an increasingly competitive and largely difficult environment. The company’s performance was anchored by diversifying our client base through strategic targeting and efficient management of our operations.

The company reported net profit of $100.254M for the quarter ended January 31, 2024, representing a decline of 15% or $17.695M relative to the corresponding period of 2023. Consequently, earnings per share decreased by 15% to $0.33 per share.

Total revenues for the quarter ended January 31, 2024 declined by $59.235M to $567.752M, reflecting a decrease of 9% over the corresponding period. This was mainly due to a one-off event for one of our major clients which is not likely to reoccur in subsequent periods.

The company was strategic in its efforts to protect the margins and the gross profit for the quarter was $315.822M compared to the $312.611M earned in 2023. This demonstrates the company’s ability to be alert and responsive to market conditions. Gross margins improved to 56%, up from 50% in the corresponding period.

The company continues to generate revenues from activities requiring reduced external support.

For more information CLICK HERE

Continue Reading

Trending

0
Would love your thoughts, please comment.x
()
x